Clinical Research IO’s Survey Finds That Coronavirus is Disrupting Clinical Research Sites
Clinical Research IO‘s recent web survey found that COVID-19 is disrupting clinical research sites worldwide. The results are indicative of a significant slowdown in new drug development and long term effects on healthcare in general. 25% of sites have stopped recruiting Of the 75% that are continuing enrollment, about half (37%) are considering halting new...